InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: capital gain post# 1541

Monday, 03/29/2021 6:32:06 PM

Monday, March 29, 2021 6:32:06 PM

Post# of 1850
Mass Vaccination in a Pandemic - Benefits versus Risks: Interview with Geert Vanden Bossche

https://www.youtube.com/watch?v=l_ksalhIi5c


Geert Vanden Bossche PhD, is an internationally recognised vaccine developer having worked as the head of the Vaccine Development Office at the German Centre for Infection Research.

Coordinated Global Alliance for Vaccines and Immunisation's Ebola Vaccine Program and contributed to the implementation of an integrated vaccine work plan in collaboration with Global Health Partners (WHO, Bill & Melinda Gates Foundation, CDC, UNICEF), regulators (FDA) and vaccine manufacturers to enable timely deployment or stockpiling of Ebola vaccine candidates.

Highlighting the principle of using a prophylactic vaccine in the midst of a pandemic. Likely to create more more viral variants in the process.

Sharing his perspective on mass vaccination in COVID-19.




I got this link from the comment section of the Hamburger link you posted elsewhere.






Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.